Credit Suisse Ag Zai Lab LTD Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Zai Lab LTD stock. As of the latest transaction made, Credit Suisse Ag holds 52,303 shares of ZLAB stock, worth $1.34 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

52,303

Holding current value

$1.34 Million

% of portfolio

0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$15.95 - $26.8 $834,232 - $1.4 Million	52,303 New	52,303 $837,000
Q1 2023 May 10, 2023	SELL	$30.21 - $48.1 $10.5 Million - $16.7 Million	-346,748 Reduced 13.6%	2,202,229 $73.2 Million
Q4 2022 Feb 13, 2023	BUY	$22.28 - $38.71 $9.6 Million - $16.7 Million	430,877 Added 20.34%	2,548,977 $78.3 Million
Q3 2022 Nov 10, 2022	SELL	$34.2 - $51.69 $31.8 Million - $48 Million	-928,508 Reduced 30.48%	2,118,100 $72.4 Million
Q2 2022 Aug 12, 2022	SELL	$23.14 - $49.68 $9.82 Million - $21.1 Million	-424,298 Reduced 12.22%	3,046,608 $106 Million
Q1 2022 May 16, 2022	BUY	$27.77 - $64.4 $15.1 Million - $34.9 Million	542,314 Added 18.52%	3,470,906 $153 Million
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $79.7 Million - $153 Million	1,450,960 Added 98.19%	2,928,592 $184 Million
Q3 2021 Nov 12, 2021	SELL	$105.0 - $178.37 $3.37 Million - $5.73 Million	-32,109 Reduced 2.13%	1,477,632 $156 Million
Q2 2021 Aug 16, 2021	SELL	$125.11 - $180.0 $28.5 Million - $41 Million	-227,526 Reduced 13.1%	1,509,741 $267 Million
Q1 2021 May 14, 2021	BUY	$126.27 - $191.71 $31.3 Million - $47.5 Million	247,909 Added 16.65%	1,737,267 $232 Million
Q4 2020 Feb 12, 2021	BUY	$81.94 - $135.34 $13.6 Million - $22.5 Million	165,935 Added 12.54%	1,489,358 $202 Million
Q3 2020 Nov 13, 2020	BUY	$73.3 - $89.48 $1.02 Million - $1.25 Million	13,945 Added 1.06%	1,323,423 $110 Million
Q2 2020 Aug 12, 2020	BUY	$48.82 - $82.53 $284,278 - $480,572	5,823 Added 0.45%	1,309,478 $108 Million
Q1 2020 May 13, 2020	SELL	$39.1 - $62.9 $12.4 Million - $20 Million	-318,310 Reduced 19.62%	1,303,655 $67.1 Million
Q4 2019 Feb 12, 2020	SELL	$29.79 - $43.06 $765,513 - $1.11 Million	-25,697 Reduced 1.56%	1,621,965 $67.5 Million
Q3 2019 Nov 12, 2019	BUY	$30.47 - $37.65 $13.7 Million - $16.9 Million	449,579 Added 37.52%	1,647,662 $53.3 Million
Q2 2019 Aug 14, 2019	BUY	$25.73 - $35.79 $4.56 Million - $6.34 Million	177,097 Added 17.35%	1,198,083 $41.8 Million
Q1 2019 May 14, 2019	BUY	$21.71 - $31.54 $12.3 Million - $17.9 Million	568,659 Added 125.72%	1,020,986 $30.1 Million
Q4 2018 Feb 13, 2019	BUY	$14.95 - $24.72 $6.76 Million - $11.2 Million	452,327 New	452,327 $10.5 Million

Others Institutions Holding ZLAB

# of Institutions

121

Shares Held

46.7M

Call Options Held

223K

Put Options Held

588K

Janus Henderson Group PLC London, X0

8.76M
Shares

$225 Million
0.11% of portfolio
Wellington Management Group LLP Boston, MA

8.44M
Shares

$217 Million
0.04% of portfolio
Capital World Investors Los Angeles, CA

6.44M
Shares

$165 Million
0.02% of portfolio
Viking Global Investors LP

1.95M
Shares

$50.1 Million
0.18% of portfolio
Bamco Inc New York, NY

1.91M
Shares

$49 Million
0.13% of portfolio

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.52B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account